{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T21:17:04Z","timestamp":1760908624326,"version":"build-2065373602"},"reference-count":23,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005366","name":"Universitetet i Oslo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005366","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012446","name":"Akershus Universitetssykehus","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012446","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.cyto.2015.01.020","type":"journal-article","created":{"date-parts":[[2015,3,5]],"date-time":"2015-03-05T21:00:29Z","timestamp":1425589229000},"page":"122-127","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Osteoprotegerin concentrations in patients with suspected reversible myocardial ischemia: Observations from the Akershus Cardiac Examination (ACE) 1 Study"],"prefix":"10.1016","volume":"73","author":[{"given":"Ragnhild","family":"R\u00f8ysland","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helge","family":"R\u00f8sj\u00f8","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arne Didrik","family":"H\u00f8iseth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Gullestad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pirouz","family":"Badr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gunnhild","family":"Kravdal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Torbj\u00f8rn","family":"Omland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2015.01.020_b0005","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.tem.2012.05.005","article-title":"New insights into osteoclastogenic signaling mechanisms","volume":"23","author":"Nakashima","year":"2012","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.cyto.2015.01.020_b0010","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1016\/j.jacc.2010.03.013","article-title":"Osteoprotegerin as a predictor of coronary artery disease and cardiovascular mortality and morbidity","volume":"55","author":"Venuraju","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cyto.2015.01.020_b0015","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1161\/ATVBAHA.109.199661","article-title":"Biomarkers of the osteoprotegerin pathway: clinical correlates, subclinical disease, incident cardiovascular disease, and mortality","volume":"30","author":"Lieb","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cyto.2015.01.020_b0020","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/j.1538-7836.2011.04222.x","article-title":"Serum osteoprotegerin is a predictor for incident cardiovascular disease and mortality in a general population: the Tromso Study","volume":"9","author":"Vik","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.cyto.2015.01.020_b0025","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.jacc.2007.09.058","article-title":"Circulating osteoprotegerin levels and long-term prognosis in patients with acute coronary syndromes","volume":"51","author":"Omland","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cyto.2015.01.020_b0030","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1136\/heartjnl-2011-301260","article-title":"Osteoprotegerin and cardiovascular mortality in patients with non-ST elevation acute coronary syndromes","volume":"98","author":"Roysland","year":"2012","journal-title":"Heart"},{"key":"10.1016\/j.cyto.2015.01.020_b0035","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.ahj.2010.05.015","article-title":"Prognostic value of osteoprotegerin in chronic heart failure: the GISSI-HF trial","volume":"160","author":"Roysland","year":"2010","journal-title":"Am Heart J"},{"key":"10.1016\/j.cyto.2015.01.020_b0040","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1161\/CIRCHEARTFAILURE.110.957332","article-title":"Osteoprotegerin predicts progression of chronic heart failure: results from CORONA","volume":"4","author":"Ueland","year":"2011","journal-title":"Circ Heart fail"},{"key":"10.1016\/j.cyto.2015.01.020_b0045","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1373\/clinchem.2012.190868","article-title":"Troponin I measured by a high-sensitivity assay in patients with suspected reversible myocardial ischemia: data from the Akershus Cardiac Examination (ACE) 1 study","volume":"58","author":"Rosjo","year":"2012","journal-title":"Clin Chem"},{"key":"10.1016\/j.cyto.2015.01.020_b0050","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.clinbiochem.2012.05.010","article-title":"Diagnostic utility of a single-epitope sandwich B-type natriuretic peptide assay in stable coronary artery disease: data from the Akershus Cardiac Examination (ACE) 1 study","volume":"45","author":"Rosjo","year":"2012","journal-title":"Clin Biochem"},{"key":"10.1016\/j.cyto.2015.01.020_b0055","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1042\/CS20110557","article-title":"Cardiac troponin T levels and exercise stress testing in patients with suspected coronary artery disease: the Akershus Cardiac Examination (ACE) 1 Study","volume":"122","author":"Roysland","year":"2012","journal-title":"Clin Sci"},{"key":"10.1016\/j.cyto.2015.01.020_b0060","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.regpep.2013.06.003","article-title":"Effect of short- and long-term physical activities on circulating granin protein levels","volume":"185","author":"Rosjo","year":"2013","journal-title":"Regul Pept"},{"key":"10.1016\/j.cyto.2015.01.020_b0065","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000180580","article-title":"Prediction of creatinine clearance from serum creatinine","volume":"16","author":"Cockcroft","year":"1976","journal-title":"Nephron"},{"key":"10.1016\/j.cyto.2015.01.020_b0070","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.2337\/dc07-0992","article-title":"Osteoprotegerin: a novel independent marker for silent myocardial ischemia in asymptomatic diabetic patients","volume":"30","author":"Avignon","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cyto.2015.01.020_b0075","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1177\/1479164112440815","article-title":"Osteoprotegerin, leptin and IL-6: association with silent myocardial ischemia in type 2 diabetes mellitus","volume":"10","author":"Guzel","year":"2013","journal-title":"Diabetes Vasc Dis Res"},{"key":"10.1016\/j.cyto.2015.01.020_b0080","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/1475-2840-10-76","article-title":"Plasma osteoprotegerin is related to carotid and peripheral arterial disease, but not to myocardial ischemia in type 2 diabetes mellitus","volume":"10","author":"Poulsen","year":"2011","journal-title":"Cardiovasc diabetol"},{"key":"10.1016\/j.cyto.2015.01.020_b0085","doi-asserted-by":"crossref","first-page":"593","DOI":"10.2337\/dc07-1771","article-title":"Osteoprotegerin, thiazolidinediones treatment, and silent myocardial ischemia in type 2 diabetic patients","volume":"31","author":"Sultan","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cyto.2015.01.020_b0090","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.ijcard.2008.05.048","article-title":"Osteoprotegerin and B-type natriuretic peptide in acute coronary syndromes with preserved systolic function: relation to coronary artery disease extension","volume":"137","author":"Palazzuoli","year":"2009","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cyto.2015.01.020_b0095","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/jcp.20354","article-title":"Osteoprotegerin (OPG) is localized to the Weibel\u2013Palade bodies of human vascular endothelial cells and is physically associated with von Willebrand factor","volume":"204","author":"Zannettino","year":"2005","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.cyto.2015.01.020_b0100","first-page":"4","article-title":"Hypertensive stretch regulates endothelial exocytosis of Weibel\u2013Palade bodies through VEGF receptor 2 signaling pathways","author":"Xiong","year":"2013","journal-title":"Cell Res"},{"key":"10.1016\/j.cyto.2015.01.020_b0105","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1161\/01.ATV.0000209501.56852.6c","article-title":"Dynamics and plasticity of Weibel\u2013Palade bodies in endothelial cells","volume":"26","author":"Rondaij","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cyto.2015.01.020_b0110","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.thromres.2013.03.001","article-title":"An ELISA for the quantitation of von Willebrand factor: osteoprotegerin complexes in plasma","volume":"131","author":"Vinholt","year":"2013","journal-title":"Thromb Res"},{"key":"10.1016\/j.cyto.2015.01.020_b0115","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.ejheart.2006.10.015","article-title":"Increased circulating concentrations and augmented myocardial extraction of osteoprotegerin in heart failure due to left ventricular pressure overload","volume":"9","author":"Helske","year":"2007","journal-title":"Eur J Heart Fail"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466615000393?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466615000393?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T20:49:51Z","timestamp":1760906991000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466615000393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S1043466615000393"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2015.01.020","relation":{},"ISSN":["1043-4666"],"issn-type":[{"type":"print","value":"1043-4666"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Osteoprotegerin concentrations in patients with suspected reversible myocardial ischemia: Observations from the Akershus Cardiac Examination (ACE) 1 Study","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2015.01.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}